Relapsed Small Lymphocytic Lymphoma Recruiting Phase 2 Trials for Cyclophosphamide (DB00531)

IndicationStatusPhase
DBCOND0023539 (Relapsed Small Lymphocytic Lymphoma)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02722668UCB Transplant for Hematological Diseases Using a Non Myeloablative PrepTreatment